Want to see LBRX full AI Analyst Report?
LB Pharmaceuticals, Inc. (LBRX) Stock Forecast & Price Target
51 Followers
LBRX Analyst Ratings
Strong Buy
9Buy1Hold0Sell
Based on 10 analysts giving stock ratings to LB Pharmaceuticals, Inc. in the past 3 months
LBRX Stock 12 Month Forecast
Average Price Target
$60.70▲(59.36% Upside)Based on 10 Wall Street analysts offering 12 month price targets for LB Pharmaceuticals, Inc. in the last 3 months. The average price target is $60.70 with a high forecast of $80.00 and a low forecast of $35.00. The average price target represents a 59.36% change from the last price of $38.09.
Past 12 Months12 Month ForecastJan2026Oct2026
High$80.00
Average$60.70
Low$35.00
Highest Price TargetHighest$80.00Average Price Target$60.70Lowest Price TargetLowest$35.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Yasmeen Rahimi | Piper Sandler | $78 | buy | 104.78%Upside | Reiterated | 11/06/26 | ||
| Boobalan Pachaiyappan | Roth MKM | $35 | hold | -8.11%Downside | Reiterated | 11/06/26 | ||
| Delma Caiati | Guggenheim | $80 | buy | 110.03%Upside | Reiterated | 11/05/26 | ||
| Malcolm Hoffman | BMO Capital | $54 | buy | 41.77%Upside | Reiterated | 11/05/26 | ||
| Ram Selvaraju | H.C. Wainwright | $45→$60 | buy | 57.52%Upside | Reiterated | 11/02/26 | ||
| Sumant Kulkarni | Canaccord Genuity | $65 | buy | 70.65%Upside | Reiterated | 10/28/26 | ||
| Paul Matteis | Stifel Nicolaus | $53 | buy | 39.14%Upside | Reiterated | 10/21/26 | ||
| Ami Fadia | Needham | $68 | buy | 78.52%Upside | Initiated | 10/02/26 | ||
| Kaveri Pohlman | Clear Street | $45→$69 | buy | 81.15%Upside | Assigned | 08/21/26 | ||
| Adam Vogel | Craig-Hallum | $36→$45 | buy | 18.14%Upside | Reiterated | 08/12/26 | ||
| Rudy Li | Wolfe Research | $45 | buy | 18.14%Upside | Initiated | 07/07/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Yasmeen RahimiPiper Sandler | BuyReiterated$78 | 11/06/26 | 104.78%Upside | ||
| Boobalan PachaiyappanRoth MKM | HoldReiterated$35 | 11/06/26 | -8.11%Downside | ||
| Delma CaiatiGuggenheim | BuyReiterated$80 | 11/05/26 | 110.03%Upside | ||
| Malcolm HoffmanBMO Capital | BuyReiterated$54 | 11/05/26 | 41.77%Upside | ||
| Ram SelvarajuH.C. Wainwright | BuyReiterated$45→$60 | 11/02/26 | 57.52%Upside | ||
| Sumant KulkarniCanaccord Genuity | BuyReiterated$65 | 10/28/26 | 70.65%Upside | ||
| Paul MatteisStifel Nicolaus | BuyReiterated$53 | 10/21/26 | 39.14%Upside | ||
| Ami FadiaNeedham | BuyInitiated$68 | 10/02/26 | 78.52%Upside | ||
| Kaveri PohlmanClear Street | BuyAssigned$45→$69 | 08/21/26 | 81.15%Upside | ||
| Adam VogelCraig-Hallum | BuyReiterated$36→$45 | 08/12/26 | 18.14%Upside | ||
| Rudy LiWolfe Research | BuyInitiated$45 | 07/07/26 | 18.14%Upside |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering LB Pharmaceuticals, Inc.
3 Months
Success Rate3/4 ratings generated profit
75%
Average Return
+28.15%
Copying Adam Vogel's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +28.15% per trade.
1 Year
Success Rate3/4 ratings generated profit
75%
Average Return
+22.90%
Copying Adam Vogel's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +22.90% per trade.
2 Years
Success Rate3/4 ratings generated profit
75%
Average Return
+22.90%
Copying Adam Vogel's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +22.90% per trade.
LBRX Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 2 | 9 | 12 |
| Buy | 7 | 10 | 8 | 7 | 3 |
| Hold | 0 | 0 | 0 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 13 | 14 | 10 | 17 | 17 |
In the current month, LBRX has received 15 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. LBRX average Analyst price target in the past 3 months is 60.70.
LBRX Financial Forecast
High$-1.33
Consensus$-1.76
Low$-2.38
LBRX Earnings Forecast
Next quarter’s earnings estimate for LBRX is -$1.76 with a range of -$2.38 to -$1.33. The previous quarter’s EPS was -$1.79. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
High$0.00
Consensus$0.00
Low$0.00
LBRX Sales Forecast
Next quarter’s sales forecast for LBRX is $0 with a range of $0 to $0. The previous quarter’s sales results were ―. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
LBRX Stock Forecast FAQ
What is LBRX’s average 12-month price target, according to analysts?
Based on analyst ratings, LB Pharmaceuticals, Inc.’s 12-month average price target is $60.70.
What is LBRX’s upside potential, based on the analysts’ average price target?
LB Pharmaceuticals, Inc. has 59.36% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LBRX a Buy, Sell or Hold?
LB Pharmaceuticals, Inc. has a consensus rating of Strong Buy which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
What is LB Pharmaceuticals, Inc.’s price target?
The average price target for LB Pharmaceuticals, Inc. is $60.70. This is based on 10 12-month price targets, issued in the past 3 months. The highest analyst price target is $80.00, the lowest forecast is $35.00. The average price target represents a 59.36% increase from the current price of $38.09.
What do analysts say about LB Pharmaceuticals, Inc.?
LB Pharmaceuticals, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of LBRX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
